Skip to main content
Clinical Trials/EUCTR2020-005827-35-FR
EUCTR2020-005827-35-FR
Active, not recruiting
Phase 1

SARS-CoV-2 neurotropism, micRoglial ActivatioN and cytokine dySregulaTiOn in COVID-19 patients with delirium - BRAINSTORM

niversity Hospital of Toulouse0 sites25 target enrollmentDecember 11, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospital of Toulouse
Enrollment
25
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 11, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity Hospital of Toulouse

Eligibility Criteria

Inclusion Criteria

  • \- Adult patients (male or female \> or \= 18 years)
  • \- COVID\-19 (positive respiratory track PCR test \< 30 days)
  • \- Delirium (CAM\-ICU criteria)
  • \- informed and written consent to participate in the study by patient’s surrogate
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 20
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 5

Exclusion Criteria

  • \- medical decision of withdrawal of life sustaining treatments previous to patients recruitment
  • \- former neurological or psychiatric disability
  • \- MRI or PET scan contraindication
  • \- pregnancy or breastfeeding
  • \- hemodynamic or respiratory failure precluding patient’s transport / MRI or PET scanning

Outcomes

Primary Outcomes

Not specified

Similar Trials